{"id":178636,"date":"2022-08-24T07:52:05","date_gmt":"2022-08-24T07:52:05","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=178636"},"modified":"2023-08-08T05:25:53","modified_gmt":"2023-08-08T05:25:53","slug":"international-normalized-ratio","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/","title":{"rendered":"International normalized ratio"},"content":{"rendered":"<p>The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.<\/p>\n<hr \/>\n<p>A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.<\/p>\n<hr \/>\n<div class=\"group w-full text-token-text-primary border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-3 overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients&#8217; anticoagulation status.<\/p>\n<hr \/>\n<div class=\"group w-full text-token-text-primary border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-3 overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual&#8217;s blood with a reference time.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-178636","post","type-post","status-publish","format-standard","hentry","category-i"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>International normalized ratio - Definition of International normalized ratio<\/title>\n<meta name=\"description\" content=\"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients&#039; anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual&#039;s blood with a reference time.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"International normalized ratio - Definition of International normalized ratio\" \/>\n<meta property=\"og:description\" content=\"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients&#039; anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual&#039;s blood with a reference time.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-24T07:52:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-08T05:25:53+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/\",\"name\":\"International normalized ratio - Definition of International normalized ratio\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-08-24T07:52:05+00:00\",\"dateModified\":\"2023-08-08T05:25:53+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients' anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual's blood with a reference time.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"International normalized ratio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"International normalized ratio - Definition of International normalized ratio","description":"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients' anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual's blood with a reference time.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/","og_locale":"en_US","og_type":"article","og_title":"International normalized ratio - Definition of International normalized ratio","og_description":"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients' anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual's blood with a reference time.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/","og_site_name":"Glossary","article_published_time":"2022-08-24T07:52:05+00:00","article_modified_time":"2023-08-08T05:25:53+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/","name":"International normalized ratio - Definition of International normalized ratio","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-08-24T07:52:05+00:00","dateModified":"2023-08-08T05:25:53+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The standard measurement of oral anticoagulation, introduced by the World Health Organization (WHO) in 1983 to replace the prothrombin time (PT). When a patient\u2019s blood is tested to determine its level of anticoagulation, the sample is treated with a thromboplastin, a laboratory reagent that may vary considerably depending on its chemical constituents. As a result, a single sample of blood tested in several different laboratories may give different PT results. To resolve the potential difficulties that this may create for patients who need to achieve a stable level of anticoagulation, the WHO has created the INR to be a rating scale for thromboplastins used around the world that standardizes the PT result.A standardized formula utilized to adjust variables that influence prothrombin time, ensuring consistent and comparable results across various laboratories and regions. This adjustment is primarily employed for patients undergoing warfarin therapy.The abbreviation for International Normalized Ratio (INR), a metric employed in the monitoring of anticoagulant drugs. It enables standardized measurement of patients' anticoagulation status.A standard set by the World Health Organization to uniformly regulate anticoagulant drug treatment across the globe. This ratio is determined by contrasting the prothrombin time of an individual's blood with a reference time.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/international-normalized-ratio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"International normalized ratio"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=178636"}],"version-history":[{"count":5,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178636\/revisions"}],"predecessor-version":[{"id":236107,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178636\/revisions\/236107"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=178636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=178636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=178636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}